Classification histologique et moléculaire des cancers de l’endomètre et leurs implications dans la thérapeutique
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Bulletin du Cancer
- Vol. 104 (12) , 1001-1012
Abstract
No abstract availableKeywords
Funding Information
- Fondation ARC pour la Recherche sur le Cancer
- Institut National du Cancer (INCa)
This publication has 61 references indexed in Scilit:
- New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical careGynecologic Oncology Research and Practice, 2016
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiativeLaboratory Investigation, 2015
- Etiologic heterogeneity in endometrial cancer: Evidence from a Gynecologic Oncology Group trialGynecologic Oncology, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical studyVirchows Archiv, 2010
- Endometrial hyperplasia and the risk of progression to carcinomaMaturitas, 2009
- Hormones and endometrial cancer—new data from the Million Women StudyThe Lancet, 2005
- Expression of EGFR, HER-2/neu, P53, and PCNA in Endometrioid, Serous Papillary, and Clear Cell Endometrial AdenocarcinomasGynecologic Oncology, 1994
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983